Seth Lederman

Seth Lederman

Company: CEO & Chairman Tonix Pharmaceuticals

Job title: Co-Founder


Seth Lederman is founder and CEO of Tonix.  Prior to founding Tonix, Dr. Lederman founded Vela, Targent, and Validus Pharmaceuticals.  Targent was acquired by Spectrum Pharmaceuticals, which marketed Targent’s levoleucovorin as Fusilev® for advanced colorectal cancer. Dr. Lederman was on the faculty of Columbia University medical school from 1985 – 2017 (Asst. Prof 1988 – 1996 and then Assoc. Prof with tenure.)  Dr. Lederman earned an AB from Princeton in Chemistry cum laude in 1979 and an MD from Columbia University’s College of Physicians and Surgeons in 1983. Dr. Lederman trained in internal medicine and rheumatology at Columbia’s Presbyterian Hospital.


Live Q&A 12:20 pm

Read more

day: Day Two

Developing a PTSD Therapeutic – Phase 3 Clinical Development 11:55 am

Targeting disturbed sleep in PTSD to facilitate recovery Role of time-since-trauma in treatment responsiveness Trimodal mechanism of action of cyclobenzaprine; enhancement by dynamic diurnal pharmacokinetic deliveryRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.